Crossmark

LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer’s disease brains

Crossref DOI link: https://doi.org/10.1186/s40478-019-0715-5

Published Online: 2019-05-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mórotz, Gábor M.

Glennon, Elizabeth B.

Gomez-Suaga, Patricia

Lau, Dawn H. W.

Robinson, Eleanor D.

Sedlák, Éva

Vagnoni, Alessio

Noble, Wendy

Miller, Christopher C. J. http://orcid.org/0000-0002-5130-1845
Funding

Funding for this research was provided by:

Biotechnology and Biological Sciences Research Council (BB/L019299/1)

Alzheimer’s Research UK (ARUK-PG2017B-3)

Alzheimer’s Research UK (ART-PG2011-5)
License Information

Text and Data Mining valid from 2019-05-08
More Information

Article History

Received: 11 February 2019

Accepted: 4 April 2019

First Online: 8 May 2019

Ethics approval and consent to participate

: Post-mortem human brain tissues were obtained from the MRC Neurodegenerative Diseases Brain Bank, King’s College London. All tissue collection and processing were carried out under the regulations and licensing of the Human Tissue Authority, and in accordance with the Human Tissue Act, 2004.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.